Skip to main content

Articles

Conquering COPD: Value-Based Perspectives for Providers and Payers
Read More
FDA Approvals, Payers' Guide
The Year 2015 Had Highest Number of Drug Approvals in the New Millennium, but with Controversy
Read More
FDA Approvals, Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2015
Read More
FDA Approvals, Payers' Guide
Welcome to the Seventh Annual Payers' Guide to New FDA Approvals
Read More
FDA Approvals, Payers' Guide
Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients with Schizophrenia
Read More
FDA Approvals, Payers' Guide
Cosentyx (Secukinumab): First IL-17A Antagonist Receives FDA Approval for Moderate-to-Severe Plaque Psoriasis
Read More
FDA Approvals, Payers' Guide
Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients with Heart Failure
Read More
FDA Approvals, Payers' Guide
Therapeutic Leap for Multiple Myeloma in 2015: Unprecedented FDA Drug Approvals
Read More
FDA Approvals, Payers' Guide
Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Heart Failure
Read More
FDA Approvals, Payers' Guide
Darzalex (Daratumumab): First Anti-CD38 Monoclonal Antibody Approved for Patients with Relapsed Multiple Myeloma
Read More
Page 115 of 245
Results 1141 - 1150 of 2441